Andon Health Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Andon Health.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth	26.5%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

Andon Health Co., Ltd.'s (SZSE:002432) Earnings Are Not Doing Enough For Some Investors

Nov 18

Andon Health (SZSE:002432) Is Doing The Right Things To Multiply Its Share Price

Oct 16

Andon Health's (SZSE:002432) Weak Earnings May Only Reveal A Part Of The Whole Picture

May 08

Andon Health Co., Ltd. (SZSE:002432) Stock Rockets 28% But Many Are Still Ignoring The Company

Mar 22

Andon Health's (SZSE:002432) Returns On Capital Are Heading Higher

Mar 19

A Look At The Fair Value Of Andon Health Co., Ltd. (SZSE:002432)

Mar 01

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Andon Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SZSE:002432 - Analysts future estimates and past financials data (CNY Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
9/30/2024	2,578	1,724	663	713	N/A
6/30/2024	2,299	1,068	446	496	N/A
3/31/2024	2,498	898	959	1,163	N/A
12/31/2023	3,231	1,252	1,557	1,770	N/A
9/30/2023	4,471	877	2,023	2,272	N/A
6/30/2023	5,332	1,572	2,687	2,975	N/A
3/31/2023	6,074	2,320	6,159	6,277	N/A
1/1/2023	26,315	16,030	18,010	18,222	N/A
9/30/2022	26,196	16,909	17,868	18,067	N/A
6/30/2022	25,095	16,097	17,065	17,227	N/A
3/31/2022	23,812	15,182	12,878	13,050	N/A
1/1/2022	2,397	909	223	293	N/A
9/30/2021	1,191	-71	-69	-21	N/A
6/30/2021	1,537	39	117	158	N/A
3/31/2021	2,029	234	318	367	N/A
12/31/2020	2,008	242	408	462	N/A
9/30/2020	1,801	509	376	443	N/A
6/30/2020	1,424	374	180	252	N/A
3/31/2020	856	148	-3	52	N/A
12/31/2019	706	66	-104	-44	N/A
9/30/2019	668	-6	-112	-58	N/A
6/30/2019	620	9	-200	-61	N/A
3/31/2019	594	3	-290	-115	N/A
12/31/2018	564	13	-284	-104	N/A
9/30/2018	531	-139	-303	-94	N/A
6/30/2018	538	-164	N/A	-105	N/A
3/31/2018	582	-175	N/A	-84	N/A
12/31/2017	598	-166	N/A	-92	N/A
9/30/2017	556	26	N/A	-17	N/A
6/30/2017	566	10	N/A	-37	N/A
3/31/2017	445	13	N/A	-50	N/A
12/31/2016	420	14	N/A	-36	N/A
9/30/2016	431	-183	N/A	-97	N/A
6/30/2016	384	-154	N/A	-128	N/A
3/31/2016	403	-148	N/A	-115	N/A
12/31/2015	398	-151	N/A	-129	N/A
9/30/2015	368	-27	N/A	-171	N/A
6/30/2015	391	-22	N/A	-119	N/A
3/31/2015	430	-7	N/A	-88	N/A
12/31/2014	425	10	N/A	-69	N/A
9/30/2014	433	-45	N/A	-90	N/A
6/30/2014	429	-23	N/A	-56	N/A
3/31/2014	431	-10	N/A	-72	N/A
12/31/2013	408	-9	N/A	-74	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 002432's forecast earnings growth is above the savings rate (2.8%).

Earnings vs Market: Insufficient data to determine if 002432's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 002432's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 002432's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 002432's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 002432's Return on Equity is forecast to be high in 3 years time

Andon Health Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Andon Health Co., Ltd.'s (SZSE:002432) Earnings Are Not Doing Enough For Some Investors

Third quarter 2024 earnings released: EPS: CN¥1.85 (vs CN¥0.24 in 3Q 2023)

Andon Health (SZSE:002432) Is Doing The Right Things To Multiply Its Share Price

Andon Health Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Investor sentiment improves as stock rises 18%

These 4 Measures Indicate That Andon Health (SZSE:002432) Is Using Debt Safely

Second quarter 2024 earnings released: EPS: CN¥0.83 (vs CN¥0.39 in 2Q 2023)

Andon Health Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Market Cool On Andon Health Co., Ltd.'s (SZSE:002432) Earnings

Insufficient new directors

Dividend of CN¥0.30 announced

Andon Health Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 04 June 2024

Is Andon Health (SZSE:002432) Using Too Much Debt?

Andon Health's (SZSE:002432) Weak Earnings May Only Reveal A Part Of The Whole Picture

Investor sentiment improves as stock rises 17%

Andon Health Co., Ltd., Annual General Meeting, May 21, 2024

Andon Health Co., Ltd. to Report Q1, 2024 Results on Apr 29, 2024

Andon Health Co., Ltd. (SZSE:002432) Stock Rockets 28% But Many Are Still Ignoring The Company

Investor sentiment improves as stock rises 15%

Andon Health's (SZSE:002432) Returns On Capital Are Heading Higher

A Look At The Fair Value Of Andon Health Co., Ltd. (SZSE:002432)

Investor sentiment improves as stock rises 20%

Now 21% undervalued after recent price drop

Investor sentiment improves as stock rises 15%

Andon Health Co., Ltd. to Report Fiscal Year 2023 Results on Apr 29, 2024

Third quarter 2023 earnings released: EPS: CN¥0.24 (vs CN¥1.77 in 3Q 2022)

Andon Health Co., Ltd. (SZSE:002432) announces an Equity Buyback for CNY 1,000 million worth of its shares.

Second quarter 2023 earnings released: EPS: CN¥0.39 (vs CN¥2.04 in 2Q 2022)

Now 20% undervalued after recent price drop

Andon Health Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 13 June 2023

Andon Health Co., Ltd. Approves Dividend for 2022

Andon Health Co., Ltd., Annual General Meeting, May 22, 2023

First quarter 2023 earnings released: EPS: CN¥1.28 (vs CN¥31.39 in 1Q 2022)

Andon Health Co., Ltd. Announces Executive Changes

No independent directors

Third quarter 2022 earnings released: EPS: CN¥1.77 (vs CN¥0.01 loss in 3Q 2021)

Andon Health Co., Ltd. Approves Cash Dividend for the Year 2021

Andon Health Co., Ltd. Proposes Final Cash Dividend for the Year 2021

Andon Health Co., Ltd., Annual General Meeting, May 20, 2022

First quarter 2022 earnings released: EPS: CN¥31.39 (vs CN¥0.085 in 1Q 2021)

Insufficient new directors

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS: CN¥2.01 (vs CN¥0.56 in FY 2020)

Third quarter 2021 earnings released: CN¥0.01 loss per share (vs CN¥0.24 profit in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.037 (vs CN¥0.49 in 2Q 2020)

Andon Health Co., Ltd. (SZSE:002432) announces an Equity Buyback for CNY 100 million worth of its shares.

Andon Health Co., Ltd. Announces 2020 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 03 June 2021

Andon Health Co., Ltd. Approves Cash Dividend for 2020

Third quarter 2020 earnings released: EPS CN¥0.24 (vs CN¥0.069 loss in 3Q 2019)

Andon Health Co., Ltd. Proposes Final Cash Dividend for 2020

Andon Health Co., Ltd. (SZSE:002432) announces an Equity Buyback for CNY 100 million worth of its shares.

New 90-day low: CN¥8.43

New 90-day low: CN¥9.27

New 90-day low: CN¥9.33

New 90-day low: CN¥10.26

New 90-day low - CN¥10.30

First half earnings released

Andon Health Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies